What is the Share Price of Astal Laboratories Ltd?

Astal Laboratories Ltd share price is ₹96.00 As on 31 October, 2025|18:39

Home
>
Stocks
>
Astal Laboratories Ltd

Astal Laboratories Ltd Share Price

Q: What is the Market Cap of Astal Laboratories Ltd?

The Market Cap of Astal Laboratories Ltd is ₹106 As on 31 October, 2025|18:39

Q: What is PE Ratio of Astal Laboratories Ltd?

The P/E ratio of Astal Laboratories Ltd is 11.3 As on 31 October, 2025|18:39

Q: What is PB Ratio of Astal Laboratories Ltd?

The PB ratio of Astal Laboratories Ltd is 2.62 As on 31 October, 2025|18:39

₹ 0.00 0 (0%)
Updated on 01-01-1970 5:30 AM

Stock Rating

BSE

Pros 2

Cons 8

Astal Laboratories Ltd Price Performance

Day's Low
₹0

Day's High
₹0

₹ 0

52-w low
₹0

52-w high
₹0

Day's open
₹0
Previous close
₹0
VWAP
₹0
Lower price band
₹0
Upper price band
₹0

Today's Market Action

Its last traded stock price on BSE was 96.00 down by -2.12%. The total volume of shares on NSE and BSE combined was 35,353 shares. Its total combined turnover was Rs 0.34 crores.

Astal Laboratories Ltd Medium and Long Term Market Action

The stock price of Astal Laboratories Ltd is down by 0% over the last one month. Don't forget to check the full stock price history in the table below.

Astal Laboratories Ltd Fundamentals

Market Cap (Cr): 106
Book Value (₹):
Stock P/E:
Revenue (Cr):
Total Debt (Cr):

Face Value (₹):
Roce (%):
ROE (%):
Earnings (Cr):
Promoter’s Holdings (%):

EPS (₹):
Debt to Equity:
Dividend Yield (%):
Cash (Cr):

Astal Laboratories Ltd Mutual fund holdings and trends

FUND NAME	Quantity	Monthly Change (Qty)

Astal Laboratories Ltd Shareholding Pattern

Similar Stocks

Company	Price	Market Cap (Cr)	P/E

About Astal Laboratories Ltd

Data not available.

Astal Laboratories Ltd FAQ's

What is Share Price of Astal Laboratories Ltd?

What is the Market Cap of Astal Laboratories Ltd?

What is PE Ratio of Astal Laboratories Ltd?

What is PB Ratio of Astal Laboratories Ltd?

What is the CAGR of Astal Laboratories Ltd?

How to Buy Astal Laboratories Ltd Share?

Can I buy Astal Laboratories Ltd from Samco?

How do I buy Astal Laboratories Ltd from Samco?

Financials

(*All values are in Rs. Cr)

Consolidated Financial Performace In Graph(Net Profit)

Standalone Financial Performace In Graph(Net Profit)

(*All values are in Rs. Cr)

Consolidated Financial Performace In Graph(Net Profit)

Standalone Financial Performace In Graph(Net Profit)

(*All values are in Rs. Cr)

Consolidated Financial Performace In Graph(Cash Flow)

Standalone Financial Performace In Graph(Cash Flow)

News

Review

Pros

Strong Working Capital Cycle
The company has a great working capital cycle of 0 days which results in lower investments in working capital and higher asset turnover. This reduces capital requirement of the business and drives RoE and cash flow generation positively. This is extremely positive for long term shareholders of the business.
Above Average Growth Rate
The company is estimated to grow its earnings at a reasonable rate over the next few years which will drive shareholder value creation

Cons

Low Sustainable RoE
The company's sustainable return on equity is lower than the expected cost of capital which implies that the underlying business will destruct value over a period of time due to it's inability to generate superior returns on capital.
Low Return on Capital Employed
The company is unable to generate sufficient return on capital employed which impairs it's ability to generate high return for shareholders after accounting for taxes, interest and other non-equity stakeholders.
Poor Cash Flow Conversion
The business has very poor cash conversion ratio of only -494.69% of operating earnings getting converted into operating cash flow. This implies that increase in profits has not translated into higher cash flows for the business and incrementally higher investments in working capital which works negatively for shareholders.
Highly Cyclical Industry
The company operates an extremely cyclical business with unpredictable earnings and cash flows. This shall result in very high stock price volatility and returns which would negatively impact shareholder returns.
Low Pricing Power & High Competition
The business has extremely low pricing power and is vulnerable to competitive pressure which can significantly impact shareholder returns.
Capital Intensive Business
The company operates an extremely capital intensive business with a low Asset turnover ratio of 1.30. A low asset turnover ratio negatively impacts RoE and reduces shareholder returns. Also due to the capital intensive nature of business, growth of the business would need to be funded either via increasing borrowings or diluting shareholders, both of which shall negatively impact shareholder value and returns.
Poor Capital Allocation
The company has disproportionately high amount of assets locked up in working capital, cash and cash equivalents, loans and advances, etc to the extent of 81.94 % of total assets. This reflects poorly on the capital allocation strategy of the management which negatively impacts shareholder returns.
Poor Corporate Governance
The general corporate governance standards of the company are poor which can negatively impact shareholder value and returns.

Valuation Analysis

Margin of safety
(31/10/2025)

114

Margin of Safety Index: Very High

0% People are bullish about Astal Laboratories Ltd

0 % People are bearish about Astal Laboratories Ltd

What is your opinion about this Stock?

Historical Data

Date	Open	High	Low	Close	Volume	Daily Change %